| Richard A Kimmell, MD | |
|
1600 N 2nd St, Clinton, MO 64735-1192 | |
| (660) 885-6690 | |
| (660) 885-8496 |
| Full Name | Richard A Kimmell |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 42 Years |
| Location | 1600 N 2nd St, Clinton, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740242890 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 104043 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Macon County Samaritan Memorial Hospital | Macon, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Macon County Samaritan Hospital | 1456261395 | 35 |
News Archive
Gilead Sciences, Inc. has announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Atripla (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg). Atripla is currently sold in the United States through a joint venture between Bristol-Myers Squibb and Gilead.
Recently, Health Canada, the Canadian government's public health department, announced new sodium reduction efforts despite the latest scientific evidence.
A research team led by Dr. Khaled El Emam, the Canada Research Chair in Electronic Health Information at the CHEO Research Institute, evaluated the use of technology in Canadian clinical trials, and found that a significant proportion (41%) have moved away from collecting and managing trial data using only paper records.
HITLAB has selected five finalists for its HITLAB World Cup, an international competition that promotes original solutions to pressing healthcare challenges. The best and brightest in healthcare innovation, the finalists, will present their ideas at the HITLAB Innovators SummitSM on December 4, 2015, at Columbia University's Alfred Lerner Hall.
› Verified 8 days ago
| Entity Name | Macon County Samaritan Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548215106 PECOS PAC ID: 1456261395 Enrollment ID: O20040121000179 |
News Archive
Gilead Sciences, Inc. has announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Atripla (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg). Atripla is currently sold in the United States through a joint venture between Bristol-Myers Squibb and Gilead.
Recently, Health Canada, the Canadian government's public health department, announced new sodium reduction efforts despite the latest scientific evidence.
A research team led by Dr. Khaled El Emam, the Canada Research Chair in Electronic Health Information at the CHEO Research Institute, evaluated the use of technology in Canadian clinical trials, and found that a significant proportion (41%) have moved away from collecting and managing trial data using only paper records.
HITLAB has selected five finalists for its HITLAB World Cup, an international competition that promotes original solutions to pressing healthcare challenges. The best and brightest in healthcare innovation, the finalists, will present their ideas at the HITLAB Innovators SummitSM on December 4, 2015, at Columbia University's Alfred Lerner Hall.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard A Kimmell, MD Po Box 699, Shawnee Mission, KS 66201-0699 Ph: (913) 469-4244 | Richard A Kimmell, MD 1600 N 2nd St, Clinton, MO 64735-1192 Ph: (660) 885-6690 |
News Archive
Gilead Sciences, Inc. has announced receipt of a Paragraph IV Certification Notice Letter advising that Teva Pharmaceuticals submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Atripla (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg). Atripla is currently sold in the United States through a joint venture between Bristol-Myers Squibb and Gilead.
Recently, Health Canada, the Canadian government's public health department, announced new sodium reduction efforts despite the latest scientific evidence.
A research team led by Dr. Khaled El Emam, the Canada Research Chair in Electronic Health Information at the CHEO Research Institute, evaluated the use of technology in Canadian clinical trials, and found that a significant proportion (41%) have moved away from collecting and managing trial data using only paper records.
HITLAB has selected five finalists for its HITLAB World Cup, an international competition that promotes original solutions to pressing healthcare challenges. The best and brightest in healthcare innovation, the finalists, will present their ideas at the HITLAB Innovators SummitSM on December 4, 2015, at Columbia University's Alfred Lerner Hall.
› Verified 8 days ago
Dr. Beth Ann Hakala, D.O., PH.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 N 2nd St, Clinton, MO 64735 Phone: 660-885-5511 | |
Dr. John Currier Brown, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 N 2nd St, Clinton, MO 64735 Phone: 660-885-5511 |